首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5077篇
  免费   271篇
  国内免费   34篇
耳鼻咽喉   33篇
儿科学   66篇
妇产科学   87篇
基础医学   522篇
口腔科学   92篇
临床医学   397篇
内科学   1501篇
皮肤病学   62篇
神经病学   276篇
特种医学   271篇
外科学   995篇
综合类   16篇
预防医学   233篇
眼科学   65篇
药学   259篇
中国医学   4篇
肿瘤学   503篇
  2023年   30篇
  2022年   48篇
  2021年   128篇
  2020年   65篇
  2019年   80篇
  2018年   108篇
  2017年   87篇
  2016年   97篇
  2015年   104篇
  2014年   136篇
  2013年   161篇
  2012年   308篇
  2011年   339篇
  2010年   190篇
  2009年   115篇
  2008年   283篇
  2007年   281篇
  2006年   284篇
  2005年   277篇
  2004年   258篇
  2003年   245篇
  2002年   230篇
  2001年   112篇
  2000年   123篇
  1999年   118篇
  1998年   72篇
  1997年   52篇
  1996年   50篇
  1995年   38篇
  1994年   39篇
  1993年   33篇
  1992年   91篇
  1991年   78篇
  1990年   66篇
  1989年   80篇
  1988年   81篇
  1987年   64篇
  1986年   76篇
  1985年   51篇
  1984年   37篇
  1983年   31篇
  1982年   13篇
  1981年   16篇
  1979年   30篇
  1978年   20篇
  1977年   14篇
  1976年   12篇
  1974年   20篇
  1973年   16篇
  1967年   11篇
排序方式: 共有5382条查询结果,搜索用时 15 毫秒
991.
In this study, the potential for abdominal MR images at 4 T using a tailored coil was demonstrated using healthy volunteers. These images were compared with those obtained in the same subject at 1.5 T to discuss whether 4 T would be superior to 1.5 T in abdominal imaging. MR images at 4 T were characterized by high contrast and signal-to-noise ratios, more than 2.95 times higher than those at 1.5 T. In conclusion, abdominal MR imaging at 4 T was feasible. Furthermore, abdominal MR imaging at 4 T was superior to that at 1.5 T in qualitative and quantitative analyses.  相似文献   
992.
PURPOSE: The purpose of the study presented here was to determine the improvement in image quality of oxygen-enhanced magnetic resonance (MR) subtraction imaging obtained with a centrically reordered inversion recovery half-Fourier single-shot turbo spin-echo (c-IR-HASTE) sequence compared with that obtained with a conventional sequentially reordered inversion recovery single-shot HASTE (s-IR-HASTE) sequence for pulmonary imaging. MATERIALS AND METHODS: Oxygen-enhanced MR imaging using a 1.5 T whole body scanner was performed on 12 healthy, non-smoking volunteers. Oxygen-enhanced MR images were obtained with the coronal two-dimensional (2D) c-IR-HASTE sequence and 2D s-IR-HASTE sequence combined with respiratory triggering. For a 256x256 matrix, 132 phase-encoding steps were acquired including four steps for phase correction. Inter-echo spacing for each sequence was 4.0 ms. The effective echo time (TE) for c-IR-HASTE was 4.0 ms, and 16 ms for s-IR-HASTE. The inversion time (TI) was 900 ms. To determine the improvement in oxygen-enhanced MR subtraction imaging by c-IR-HASTE, CNRs of subtraction image, overall image quality, and image degradation of the c-IR-HASTE and s-IR-HASTE techniques were statistically compared. RESULTS: CNR, overall image quality, and image degradation of c-IR-HASTE images showed significant improvement compared to those s-IR-HASTE images (P<0.05). CONCLUSION: Centrically reordered inversion recovery half-Fourier single-shot turbo spin-echo (c-IR-HASTE) sequence enhanced the signal from the lung and improved the image quality of oxygen-enhanced MR subtraction imaging.  相似文献   
993.
994.
We aimed to clarify which steroid receptor is involved in the inhibitory effect of medroxyprogesterone acetate (MPA) on estrogen-induced endothelial nitric oxide synthase (eNOS) phosphorylation in human umbilical vein endothelial cells (HUVEC). The progesterone/glucocorticoid receptor (GR) antagonist RU-486 and introduction of GR siRNA caused attenuation of the inhibitory effect of MPA on the estrogen-induced eNOS phosphorylation and eNOS activity in HUVEC.  相似文献   
995.
IL-12 modulates T cell responses between helper T cells Th2 and Th1; however, the therapeutic potential of IL-12 for allergic diseases either directly or as an adjuvant in allergen therapy has been controversial. The role of intranasal IL-12 as an adjuvant in modulating the grass pollen allergen (GAL) therapy-induced systemic immune response and lung-specific inflammation and airway reactivity was examined in this study using a mouse model of established allergic asthma. The effects of intranasal or nebulized IL-12 with or without intranasal anti-IFN-gamma antibody were examined in groups of control and allergen-sensitized or -challenged mice. T cell cytokine patterns, antibody response profiles, pulmonary inflammation and airway reactivity were examined. Intranasal IL-12 was found to be more effective in the Th2-Th1 shifting of immune response and anti-inflammatory activity in the lung compared to nebulized IL-12 at the given doses. Intranasal IL-12 significantly decreased production of IFN-gamma, eotaxin and LTC4/D4/E4 in the lung and decreased eosinophil infiltration, resulting in attenuated airway hyper-responsiveness in GAL-sensitized (GS) mice. In contrast, intranasal IL-12 significantly increased IFN-gamma production in the thoracic lymph node cultures and decreased the IL-5/IFN-gamma ratio, suggesting a Th2-Th1 shift. Also, intranasal IL-12 increased GAL-specific IgG2a antibody response, while the IgE response remained unaffected. The systemic effects of IL-12 were IFN-gamma dependent. IL-12 induces differential expression of its own receptor beta1 and beta2 subunits in the lung tissues to augment IL-12 responsiveness. Together, these results demonstrate that intranasal IL-12 is effective in shifting the systemic immune response in the direction of Th1 in IFN-gamma-dependent manner, while decreasing pulmonary inflammation and airway reactivity independent of IFN-gamma. Thus, intranasal delivery of IL-12 may provide an approach for the treatment of asthma and may be useful as an adjuvant in local nasal immunotherapy (IT) and in asthma.  相似文献   
996.
997.
998.
Hybrid CT/angiography (angiography) system and C-arm cone beam CT provide cross-sectional imaging as an adjunct to angiography. Current interventional oncological procedures can be conducted precisely using these two technologies. In this article, several cases using a hybrid CT/angiography system are shown first, and then the advantages and disadvantages of the hybrid CT/angiography and C-arm cone beam CT are discussed with literature reviews.A hybrid CT/angiography system was developed in 1992. Professor Y. Arai, Director of the National Cancer Center, Tokyo, Japan, first introduced this system in Aichi Cancer Center (Nagoya, Japan).1 This system integrates a CT scanner and an angiography unit, which are arranged in line using a common patient table. This permits CT, conventional fluoroscopy and angiography to be performed on the same table without having to move the patient, thereby omitting the risk of needle and catheter dislocation or compromising sterile conditions owing to patient transportation. This system is used for various interventional oncologic procedures.2 Nearly 10 years ago, the initial development of the C-arm cone beam CT technology, in which CT-like images were obtained from a flat-panel detector, was reported. With the improvement in detector technology, C-arm cone beam CT is now being used in various interventions worldwide. These two technologies, which provide cross-sectional imaging as an adjunct to angiography, allow interventional oncological procedures to be precisely conducted.The question is whether there are still any roles for the hybrid CT/angiography system after the introduction of the C-arm cone beam CT. First, this article provides our experience with cases using the hybrid CT/angiography system, along with a review of the previously published literature. Then, the advantages and drawbacks of the hybrid interventional CT/angiography system and C-arm cone beam CT are summarized, and the current role of the hybrid CT/angiography system for interventional oncology is discussed.  相似文献   
999.
Short interfering RNA (siRNA) is a potent activator of the mammalian innate immune system. When considering possible clinical applications of siRNA for humans, the adverse immunostimulatory effects must also be taken into account. Here, we show that atelocollagen-mediated systemic delivery of siRNA without chemical modifications did not cause any immunostimulation in both animals and human peripheral blood mononuclear cells (PBMCs), even if the siRNA harbored an interferon (IFN)-inducible sequence. In contrast, systemic delivery of immunostimulatory RNA (isRNA)-mediated by a cationic lipid (such as Invivofectamine) induced potent type-I IFNs and inflammatory cytokines. Regarding the mechanism by which the isRNA/atelocollagen complex avoided adverse effects on immunostimulation, we revealed that this complex was not incorporated into PBMCs. On the other hand, Invivofectamine delivered isRNA into PBMCs. The use of either atelocollagen or Invivofectamine as a vehicle elicited significant and undistinguishable therapeutic effects in a contact hypersensitivity (CHS) inflammatory model mouse, when we intravenously injected the siRNA targeting monocyte chemoattractant protein-1 as the complex. For the goal of realizing siRNA-based medicines for humans, atelocollagen is an excellent and promising delivery vehicle, and it has the useful advantage of evading detection by the "radar" of innate immunity.  相似文献   
1000.
Pneumocystis pneumonia (PCP) can occur in patients with many causes of the immunocompromised state other than human immunodeficiency virus (HIV). It is quite difficult to diagnose PCP without HIV because there is no method for detecting Pneumocystis jirovecii. Thus, non-HIV PCP continues to have high mortality. Recently, loop-mediated isothermal amplification (LAMP) is becoming an established nucleic acid amplification method offering rapid, accurate, and cost-effective diagnosis of infectious diseases. We report a non-HIV PCP case successfully diagnosed by the LAMP method. It was previously reported that PCR in BALF specimens had been the most sensitive method in the diagnosis of PCP without HIV. The LAMP method would be more sensitive than conventional PCR and an effective tool in the early diagnosis of PCP.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号